Terms: = Germ cell tumor AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Treatment
698 results:
1. Repurposed Drugs Celecoxib and Fmoc-L-Leucine Alone and in Combination as Temozolomide-Resistant Antiglioma Agents-Comparative Studies on Normal and Immortalized cell Lines, and on
Uram Ł; Pieńkowska N; Misiorek M; Szymaszek Ż; Twardowska M; Siorek M; Wołowiec S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542198
[TBL] [Abstract] [Full Text] [Related]
2. Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
Saeed AM; Bentzen SM; Ahmad H; Pham L; Woodworth GF; Mishra MV
Radiat Oncol; 2024 Mar; 19(1):36. PubMed ID: 38481255
[TBL] [Abstract] [Full Text] [Related]
3. Very high-energy electron therapy as light-particle alternative to transmission proton FLASH therapy - An evaluation of dosimetric performances.
Böhlen TT; Germond JF; Desorgher L; Veres I; Bratel A; Landström E; Engwall E; Herrera FG; Ozsahin EM; Bourhis J; Bochud F; Moeckli R
Radiother Oncol; 2024 May; 194():110177. PubMed ID: 38378075
[TBL] [Abstract] [Full Text] [Related]
4. Simulating photodynamic therapy for the treatment of glioblastoma using Monte Carlo radiative transport.
Finlayson L; McMillan L; Suveges S; Steele D; Eftimie R; Trucu D; Brown CTA; Eadie E; Hossain-Ibrahim K; Wood K
J Biomed Opt; 2024 Feb; 29(2):025001. PubMed ID: 38322729
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients.
Zheng X; Fang M; Fan Y; Sun Y; Sun M; Yang A; Zhang B; Liu Q; Liu H; Zhou X; Huang T; Qin J; Wang Z; Qin M; Shen Z; Yao S; Yang J; Wang Y; Gao M
Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38261313
[TBL] [Abstract] [Full Text] [Related]
6. A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.
Lin CC; Garralda E; Schöffski P; Hong DS; Siu LL; Martin M; Maur M; Hui R; Soo RA; Chiu J; Zhang T; Ma B; Kyi C; Tan DS; Cassier PA; Sarantopoulos J; Weickhardt A; Carvajal RD; Spratlin J; Esaki T; Rolland F; Akerley W; Deschler-Baier B; Rispoli L; Samant TS; Chowdhury NR; Gusenleitner D; Kwak EL; Askoxylakis V; De Braud F
Oncoimmunology; 2024; 13(1):2290787. PubMed ID: 38170160
[TBL] [Abstract] [Full Text] [Related]
7. Copper pyrithione and zinc pyrithione induce cytotoxicity and neurotoxicity in neuronal/astrocytic co-cultured cells via oxidative stress.
Oh HN; Kim WK
Sci Rep; 2023 Dec; 13(1):23060. PubMed ID: 38155222
[TBL] [Abstract] [Full Text] [Related]
8. Development of 3D melanoma cultures on a hyaluronic acid-based scaffold with synthetic self-assembling peptides: Electroporation enhancement.
Zamuner A; Dettin M; Dall'Olmo L; Campana LG; Mognaschi ME; Conconi MT; Sieni E
Bioelectrochemistry; 2024 Apr; 156():108624. PubMed ID: 38104458
[TBL] [Abstract] [Full Text] [Related]
9. First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations.
Janku F; Kim TM; Iyer G; Spreafico A; Elez E; de Jonge M; Yamamoto N; van der Wekken AJ; Ascierto PA; Maur M; Marmé F; Kiladjian JJ; Basu S; Baffert F; Buigues A; Chen C; Cooke V; Giorgetti E; Kim J; McCarthy F; Moschetta M; Dummer R
Eur J Cancer; 2024 Jan; 196():113458. PubMed ID: 38039779
[TBL] [Abstract] [Full Text] [Related]
10. Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.
Subbiah V; Hu MI; Mansfield AS; Taylor MH; Schuler M; Zhu VW; Hadoux J; Curigliano G; Wirth L; Gainor JF; Alonso G; Adkins D; Godbert Y; Ahn MJ; Cassier PA; Cho BC; Lin CC; Zalutskaya A; Barata T; Trask P; Scalori A; Bordogna W; Heinzmann S; Brose MS
Thyroid; 2024 Jan; 34(1):26-40. PubMed ID: 38009200
[No Abstract] [Full Text] [Related]
11. Taxifolin inhibits melanoma proliferation/migration impeding USP18/Rac1/JNK/β-catenin oncogenic signaling.
Xu L; Zhang L; Zhang S; Yang J; Zhu A; Sun J; Kalvakolanu DV; Cong X; Zhang J; Tang J; Guo B
Phytomedicine; 2024 Jan; 123():155199. PubMed ID: 37995531
[TBL] [Abstract] [Full Text] [Related]
12. Survival of Patients With Head and Neck Merkel cell Cancer: Findings From the Pan-Canadian Merkel cell Cancer Collaborative.
Nayak AL; Pickett AT; Delisle M; Dingley B; Mallick R; Hamilton T; Stuart H; Talbot M; McKinnon G; Jost E; Thiboutot E; Francescutti V; Samman S; Easson A; Schellenberg A; Merchant S; La J; Vanderbeck K; Wright F; Berger-Richardson D; Hebbard P; Hershorn O; Younan R; Patocskai E; Rodriguez-Qizilbash S; Meguerditichian A; Tchuente V; Kazandjian S; Mathieson A; Hossain F; Hetu J; Corsten M; Tohmé A; Nessim C; Johnson-Obaseki S
JAMA Netw Open; 2023 Nov; 6(11):e2344127. PubMed ID: 37983027
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-Mediated Antiproliferative Effects of M1 Macrophage-Derived Extracellular Vesicles on Melanoma cells.
Saleh NA; Rode MP; Cisilotto J; Silva AH; Prigol AN; da Luz Efe F; Winter E; Filippin-Monteiro FB; Creczynski-Pasa TB
Immunol Invest; 2024 Jan; 53(1):70-89. PubMed ID: 37981469
[TBL] [Abstract] [Full Text] [Related]
14. First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors.
Leidner R; Conlon K; McNeel DG; Wang-Gillam A; Gupta S; Wesolowski R; Chaudhari M; Hassounah N; Lee JB; Ho Lee L; O'Keeffe JA; Lewis N; Pavlakis GN; Thompson JA
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37907221
[TBL] [Abstract] [Full Text] [Related]
15. Effects of treatment methods on cutaneous melanoma related mortality and all-cause mortality in Texas: TCR-Medicare 2007-2017 database.
Ramirez F; Riva H; Digbeu B; Samaniego M; Fernandez L; Mansour S; Vasquez R; Lopez DS; Chacon J
Cancer Causes Control; 2024 Feb; 35(2):265-275. PubMed ID: 37702966
[TBL] [Abstract] [Full Text] [Related]
16. Initial experience of the treatment of large glioma with microwave ablation-assisted surgical resection.
Zhao W; Chen S; Shao X; Du H; Li P; Wang F; Chen J; Feng E; Li C
J Cancer Res Ther; 2023 Aug; 19(4):995-1000. PubMed ID: 37675728
[TBL] [Abstract] [Full Text] [Related]
17. Neuroprotective Effects of Zerumbone on H
Moon HR; Yun JM
J Med Food; 2023 Sep; 26(9):641-653. PubMed ID: 37566491
[TBL] [Abstract] [Full Text] [Related]
18. Antineoplastic effects of cassava-cyanide extract on human glioblastoma (LN229) cells.
S S; Tom J; V P S; U V; Xavier J; C A J; P V M
Toxicon; 2023 Aug; 232():107200. PubMed ID: 37419285
[TBL] [Abstract] [Full Text] [Related]
19. Psychological and behavioral symptoms in patients with melanoma: A systematic review and meta-analysis.
Danielsen JT; Strøm L; Knutzen SM; Schmidt H; Amidi A; Wu LM; Zachariae R
Psychooncology; 2023 Aug; 32(8):1208-1222. PubMed ID: 37370196
[TBL] [Abstract] [Full Text] [Related]
20. Understanding Real-World treatment Patterns and Clinical Outcomes among Metastatic Melanoma Patients in Alberta, Canada.
O'Sullivan DE; Boyne DJ; Gogna P; Brenner DR; Cheung WY
Curr Oncol; 2023 Apr; 30(4):4166-4176. PubMed ID: 37185430
[TBL] [Abstract] [Full Text] [Related]
[Next]
